Drug Profile
Paracetamol combination - Sinew Pharma
Alternative Names: Hepatotoxicity-free acetaminophen prescription combination; SNP-830 and SNP-840; SNP-830/SNP-840Latest Information Update: 15 Jun 2023
Price :
$50
*
At a glance
- Originator Sinew Pharma
- Class Acetanilides; Aminophenols; Antipyretics; Non-opioid analgesics; Small molecules
- Mechanism of Action Cyclo-oxygenase 2 inhibitors; Cytochrome P 450 enzyme system inhibitors; Prostaglandin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Pain
Most Recent Events
- 15 Jun 2023 Preclinical development is ongoing in Taiwan (Sinew Pharma pipeline, June 2023)
- 15 Jun 2023 Sinew Pharma plans a clinical trial for Pain (Sinew Pharma pipeline, June 2023)
- 28 Aug 2021 No recent reports of development identified for preclinical development in Pain in Taiwan